Isabelle Peyrottes

1.3k total citations
41 papers, 901 citations indexed

About

Isabelle Peyrottes is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Isabelle Peyrottes has authored 41 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Isabelle Peyrottes's work include Breast Cancer Treatment Studies (9 papers), Thyroid Cancer Diagnosis and Treatment (9 papers) and Sarcoma Diagnosis and Treatment (7 papers). Isabelle Peyrottes is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Thyroid Cancer Diagnosis and Treatment (9 papers) and Sarcoma Diagnosis and Treatment (7 papers). Isabelle Peyrottes collaborates with scholars based in France, United States and Hungary. Isabelle Peyrottes's co-authors include F. Ettore, Paul Hofman, Jean-Marc Ferrero, J. Doyen, Jocelyn Gal, Emmanuel Chamorey, Antoîne Italiano, J. Santini, Jean‐Michel Coindre and Juliette Thariat and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

In The Last Decade

Isabelle Peyrottes

39 papers receiving 878 citations

Peers

Countries citing papers authored by Isabelle Peyrottes

Since Specialization

Citations

This map shows the geographic impact of Isabelle Peyrottes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Peyrottes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Peyrottes more than expected).

Fields of papers citing papers by Isabelle Peyrottes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Peyrottes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Peyrottes. The network helps show where Isabelle Peyrottes may publish in the future.

Co-authorship network of co-authors of Isabelle Peyrottes

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Peyrottes. A scholar is included among the top collaborators of Isabelle Peyrottes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Peyrottes. Isabelle Peyrottes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pilot Study on the Use of Untargeted Metabolomic Fingerprinting of Liquid-Cytology Fluids as a Diagnostic Tool of Malignancy for Thyroid Nodules 2023 ·Metabolites ·(unknown), (unknown), Isabelle Peyrottes, Jean‐Marie Guigonis, (unknown), Sabine Lindenthal, Jean‐Jacques Sanglier, (unknown), Juliette Haudebourg, Clair Vandersteen, Alexandre Bozec, N. Guevara, Thierry Pourcher	4
2	Relecture préopératoire en sénologie : intérêts et limites d’une validation spécialisée en oncologie 2020 ·Bulletin du Cancer ·(unknown), (unknown), Julien Viotti, Renaud Schiappa, (unknown), (unknown), (unknown), (unknown), (unknown), Yann Delpech, (unknown), (unknown), Jean-Christophe Machiavello, Juliette Haudebourg, Isabelle Peyrottes, C. Chapellier, Emmanuel Barranger	0
3	Myoma Hot Spot: Tumor-to-Tumor Metastasis of Thyroid Origin into Uterine Leiomyoma 2019 ·European Thyroid Journal ·(unknown), Antoine Iannessi, Isabelle Peyrottes, Alexis Lacout, Antoine Thyss, Pierre-Yves Marcy	9
4	Effects of proton versus photon irradiation on (lymph)angiogenic, inflammatory, proliferative and anti-tumor immune responses in head and neck squamous cell carcinoma 2017 ·Oncogenesis ·(unknown), (unknown), Sonia Martial, (unknown), Kévin Lebrigand, Nicolas Pons, Damien Ambrosetti, Isabelle Peyrottes, (unknown), J. Hérault, Maeva Dufies, J. Doyen, Gilles Pagès	48
5	Accelerated partial breast irradiation for suitable elderly women using a single fraction of multicatheter interstitial high-dose-rate brachytherapy: Early results of the Single-Fraction Elderly Breast Irradiation (SiFEBI) Phase I/II trial 2017 ·Brachytherapy ·Jean‐Michel Hannoun‐Lévi, D. Lam Cham Kee, Jocelyn Gal, Renaud Schiappa, (unknown), Mathieu Gautier, Rabia Boulahssass, Isabelle Peyrottes, Emmanuel Barranger, Jean-Marc Ferrero, Marie-Eve Chand, J. Doyen	30
6	Effect of Neoadjuvant Chemotherapy on the Surgical Treatment of Patients With Locally Advanced Breast Cancer Requiring Initial Mastectomy 2015 ·Clinical Breast Cancer ·Emmanuel Barranger, (unknown), Emmanuel Chamorey, (unknown), B. Flipo, Philippe Follana, Isabelle Peyrottes, C. Chapellier, Jean Marc Ferrero, T. Ihraï	33
7	Diagnostic Value of Immunohistochemistry for the Detection of the BRAF ^V600E Mutation in Papillary Thyroid Carcinoma: Comparative Analysis with Three DNA-Based Assays 2014 ·Thyroid ·Marius Ilié, Sandra Lassalle, Élodie Long-Mira, Christelle Bonnetaud, Olivier Bordone, (unknown), Aude Lamy, J.C. Sabourin, Juliette Haudebourg, Catherine Butori, N. Guevara, Isabelle Peyrottes, (unknown), Alexandre Bozec, J. Santini, David Capper, Andreas von Deimling, Jean‐François Emile, Véronique Hofman, Paul Hofman	51
8	Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib 2014 ·Oncoscience ·Caroline Bailleux, Guillaume Robert, (unknown), (unknown), A. Thyss, (unknown), Isabelle Peyrottes, Paul Hofman, Patrick Auberger, Frédéric Peyrade	11
9	Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome 2014 ·Biochemical and Biophysical Research Communications ·J. Doyen, C. Trastour, F. Ettore, Isabelle Peyrottes, (unknown), Jocelyn Gal, Karine Ilc, Damien Roux, Scott K. Parks, Jean-Marc Ferrero, Jacques Pouysségur	94
10	Prognostic impact of tumour multifocality in thyroid papillary microcarcinoma based on a series of 160 cases 2012 ·European Annals of Otorhinolaryngology Head and Neck Diseases ·(unknown), Isabelle Peyrottes, Emmanuel Chamorey, Juliette Haudebourg, Anne Sudaka, Danielle Benisvy, Pierre‐Yves Marcy, (unknown), F Démard, J Vallicioni, Gilles Poissonnet, O. Dassonville, J. Santini, Alexandre Bozec	19
11	Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques 2012 ·Critical Reviews in Oncology/Hematology ·(unknown), (unknown), N. Guevara, Pierre Yves Marcy, Isabelle Peyrottes, Sandra Lassalle, Alexis Lacout, (unknown), J. Santini, (unknown), (unknown), Juliette Thariat	24
12	Chemoradiation in anaplastic thyroid carcinomas 2012 ·Critical Reviews in Oncology/Hematology ·(unknown), (unknown), N. Guevara, Nicolas Fakhry, Pierre‐Yves Marcy, Sandra Lassalle, Isabelle Peyrottes, René‐Jean Bensadoun, Alexis Lacout, J. Santini, L. Cals, J.-F. Bosset, Adam S. Garden, Juliette Thariat	23
13	Diplopia as the First Symptom of an Aggressive Metastatic Rectal Stromal Tumor 2009 ·Onkologie ·(unknown), Juliette Thariat, Fanny Burel‐Vandenbos, Pierre‐Yves Bondiau, Isabelle Peyrottes, (unknown)	25
14	HMGA2 is the partner of MDM2 in well‐differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon 2008 ·International Journal of Cancer ·Antoîne Italiano, Laurence Bianchini, Frédérique Keslair, Stéphanie Bonnafous, Nathalie Cardot‐Leccia, Jean‐Michel Coindre, Jean‐Marc Dumollard, Paul Hofman, Agnès Leroux, C Mainguené, Isabelle Peyrottes, Dominique Ranchere‐Vince, Philippe Terrier, Albert Tran, Philippe Gual, Florence Pédeutour	165
15	Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers 2008 ·European Journal of Endocrinology ·Isabelle Peyrottes, Valérie Navarro, (unknown), (unknown), Laurent Bellanger, Robert Marsault, Sabine Lindenthal, F. Ettore, Jacques Darcourt, Thierry Pourcher	39
16	Le carcinome parathyroïdien 2006 ·Bulletin du Cancer ·Gilles Poissonnet, L. Castillo, Alexandre Bozec, Isabelle Peyrottes, F. Ettore, J. Santini, F Démard, O. Dassonville	7
17	Early versus Late Local Recurrences after Conservative Treatment of Breast Carcinoma: Differences in Primary Tumor Characteristics and Patient Outcome 2006 ·Oncology ·A. Courdi, (unknown), Jean-Marc Ferrero, M. Lallement, I. Raoust, F. Ettore, Isabelle Peyrottes, Emmanuel Chamorey, C. Balu–Maestro, C. Chapellier	15
18	Quand se méfier des résultats des micro et macrobiopsies guidées mammaires ? 2006 ·Journal de Radiologie ·C. Balu–Maestro, F. Ettore, C. Chapellier, Isabelle Peyrottes, (unknown)	7
19	Application of an original RT-PCR–ELISA multiplex assay for MDR1 and MRP, along with p53 determination in node-positive breast cancer patients 2000 ·British Journal of Cancer ·Jean-Marc Ferrero, M C Etienne, J. L. Formento, M Francoual, Philippe Rostagno, Isabelle Peyrottes, F. Ettore, É. Teissier, (unknown), M Namer, G. Milano	16
20	Study of the frequencies of CYP1A1 gene polymorphisms and glutathione S-transferase mu1 gene in primary breast cancers: an update with an additional 114 cases 1998 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Xavier Fontana, Isabelle Peyrottes, (unknown), (unknown), F. Ettore, Moïse Namer, Françoise I. Bussière	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact